The U.S. food industry is entering a new phase of regulatory flexibility as the U.S. Food and Drug Administration (FDA) revises how companies may label products that do not contain petroleum-based food dyes. In a February 2026 announcement, the agency outlined a shift that allows manufacturers to make “no artificial colors” claims even when products contain colors derived from natural sources.

Previously, FDA policy generally limited such claims to products with no added color of any kind. The updated approach reflects growing regulatory recognition that colors derived from natural sources may differ meaningfully from petroleum-based synthetic dyes in both consumer perception and safety considerations.

Enforcement Discretion Creates New Labeling Flexibility

FDA confirmed it has notified industry of its intent to exercise enforcement discretion for voluntary “no artificial colors” labeling claims. Under this approach, companies may now make these claims as long as their products do not contain petroleum-based synthetic colors, even if naturally derived color additives are present.

This change removes a long-standing regulatory barrier that many manufacturers cited as a deterrent to transitioning away from synthetic dyes. FDA leadership noted that labeling terminology had become confusing for consumers and restrictive for companies exploring alternative ingredients.

Expanded Approval of Naturally Derived Color Additives

Alongside the labeling update, FDA approved beetroot red as a new food color additive and expanded the permitted uses of spirulina extract, an existing naturally derived color additive. Both actions were granted in response to industry petitions and further broaden the range of alternatives available to food manufacturers.

With these approvals, FDA has now authorized six new food color options under the current administration, signaling a continued commitment to reducing reliance on petroleum-based synthetic dyes across the U.S. food supply.

Safety and Quality Oversight Remain Central

While FDA is encouraging the transition toward naturally derived colors, the agency emphasized that manufacturers retain full responsibility for ensuring the safety, purity, and appropriate use of all color additives. FDA issued additional guidance and resource reminders to support compliance with existing safety and quality requirements.

This underscores an important regulatory principle: flexibility in labeling does not equate to reduced oversight. Manufacturers must still demonstrate that approved color additives meet applicable safety standards and are used in accordance with authorized conditions.

Regulatory Implications for Food and Consumer Product Companies

FDA’s updated approach reflects a broader trend toward modernizing food labeling policy while maintaining risk-based oversight. For food, beverage, and consumer product companies, the change creates both opportunity and responsibility. Organizations may reassess labeling strategies, ingredient sourcing, and product reformulation plans, while ensuring internal quality systems and regulatory documentation remain aligned with FDA expectations.

As regulatory scrutiny of food ingredients continues to evolve, companies that proactively integrate regulatory strategy, quality assurance, and supply chain oversight will be better positioned to adapt without disruption.

How EMMA International Supports Food and Consumer Product Compliance

EMMA International supports food and consumer product organizations navigating evolving FDA expectations related to labeling, ingredient approvals, quality systems, and regulatory risk. Our teams help clients evaluate regulatory impact, strengthen compliance frameworks, and implement disciplined quality strategies that support both innovation and regulatory confidence.

As FDA continues to modernize its approach to food safety and labeling, EMMA partners with organizations to ensure compliance remains proactive, transparent, and sustainable.

For more information on how EMMA International can assist, visit www.emmainternational.com or contact us at (248) 987-4497 or info@emmainternational.com.

EMMA International

EMMA International

EMMA International Consulting Group, Inc. is a global leader in FDA compliance consulting. We focus on quality, regulatory, and compliance services for the Medical Device, Combination Products, and Diagnostics industries.

More Resources

No results found.

From strategy to execution, EMMA delivers turnkey solutions with global expertise across every initiative.

Pin It on Pinterest

Share This